Logo image of MBII

Marrone Bio Innovations Inc (MBII) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:MBII - US57165B1061 - Common Stock

0.7981
-0.2 (-20.19%)
Last: 7/12/2022, 8:00:01 PM
0.81
+0.01 (+1.49%)
After Hours: 7/12/2022, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
MBII revenue by date.MBII revenue by date.
29.37M
38.41%
38.37M
30.64%
44.31M
15.48%
57.579M
29.95%
72.42M
25.78%
91.8M
26.76%
113.641M
23.79%
143.492M
26.27%
EBITDA
YoY % growth
MBII ebitda by date.MBII ebitda by date.
-25.64M
-45.52%
-13.64M
46.80%
-11.87M
12.98%
-4.026M
66.08%
4.182M
203.86%
3.049M
-27.10%
2.267M
-25.64%
N/A
EBIT
YoY % growth
MBII ebit by date.MBII ebit by date.
-27.99M
-43.46%
-17.2M
38.55%
-15.4M
10.47%
-12.954M
15.88%
-3.57M
72.44%
-4.971M
-39.25%
-7.061M
-42.03%
N/A
Operating Margin
MBII operating margin by date.MBII operating margin by date.
-95.30%-44.83%-34.76%-22.50%-4.93%-5.42%-6.21%N/A
EPS
YoY % growth
MBII eps by date.MBII eps by date.
-0.27
-55.71%
-0.15
44.44%
-0.10
33.33%
-0.11
-7.10%
-0.02
80.95%
-0.02-0.03
-37.72%
-0.04
-40.48%

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth
-0.04
-104.00%
-0.04
-36.00%
-0.04
-36.00%
Revenue
Q2Q % growth
16.32M
29.52%
15.606M
58.28%
13.77M
27.26%
EBITDA
Q2Q % growth
-102K
83.28%
306K
117.29%
-102K
95.10%
EBIT
Q2Q % growth
-1.836M
22.20%
-2.04M
53.74%
-1.938M
65.45%

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth
-0.04
-100.00%
-0.02-0.02-96.08%
Q4 2021
Q2Q % growth
-0.03 -0.030.00-6.95%
Q3 2021
Q2Q % growth
-0.03
25.00%
-0.030.00-9.62%
Q2 2021
Q2Q % growth
-0.02
33.33%
-0.01-0.01-96.08%
Q1 2021
Q2Q % growth
-0.02
60.00%
-0.030.0124.59%
Q4 2020
Q2Q % growth
-0.03 -0.050.0241.18%
Q3 2020
Q2Q % growth
-0.04 -0.03-0.01-38.42%
Q2 2020
Q2Q % growth
-0.03 -0.060.0347.48%
Q1 2020
Q2Q % growth
-0.05 -0.04-0.01-40.06%
MBII Yearly EPS VS EstimatesMBII Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises

Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .

PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth
11.1M
0.54%
12.852M-1.752M-13.63%
Q4 2021
Q2Q % growth
10.82M
40.16%
10.43M390.5K3.74%
Q3 2021
Q2Q % growth
9.86M
11.66%
10.847M-987.363K-9.10%
Q2 2021
Q2Q % growth
12.6M
3.45%
15.718M-3.118M-19.84%
Q1 2021
Q2Q % growth
11.04M
14.40%
11.444M-404.4K-3.53%
Q4 2020
Q2Q % growth
7.72M 9.124M-1.404M-15.39%
Q3 2020
Q2Q % growth
8.83M 10.41M-1.58M-15.17%
Q2 2020
Q2Q % growth
12.18M 10.39M1.79M17.23%
Q1 2020
Q2Q % growth
9.65M 10.317M-667.3K-6.47%
MBII Yearly Revenue VS EstimatesMBII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A